Evidence map›Paper›PMID 40775063›Full record

ReviewHypertension research : official journal of the Japanese Society of Hypertension2025

The renin-angiotensin system in models of pulmonary arterial hypertension vs primary hypertension.

Yuki Nakayama, Satoru Eguchi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Response to: Comment on: The renin-angiotensin system in models of pulmonary arterial hypertension vs primary hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  2. Comment on The renin-angiotensin system in models of pulmonary arterial hypertension vs primary hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yuki NakayamaHeart Institute and Department of Surgery, Morsani College of Medicine, University of South Florida, Room 0815 MDD, 560 Channelside drive, Tampa, FL, 33602, USA. ynakayama@usf.edu.
Satoru EguchiHeart Institute and Department of Surgery, Morsani College of Medicine, University of South Florida, Room 0815 MDD, 560 Channelside drive, Tampa, FL, 33602, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Animal models of pulmonary arterial hypertension (PAH) demonstrate up-regulation of the renin angiotensin system. However, no clinical data are available to support the efficacy of angiotensin II inhibition in treatment for PAH. In this mini review, we will update the knowledge regarding regulation of the RAS system in PAH compared to primary hypertension in order to seek better treatments against PAH.

Indexed as

HypertensionHypertension, PulmonaryPulmonary Arterial HypertensionRenin-Angiotensin SystemAnimalsDisease Models, AnimalHumansAngiotensin IIPrimary hypertensionPulmonary hypertension

Identifiers

PMID40775063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.